DIURIL Drug Patent Profile
✉ Email this page to a colleague
When do Diuril patents expire, and when can generic versions of Diuril launch?
Diuril is a drug marketed by Rising and Salix Pharms and is included in two NDAs.
The generic ingredient in DIURIL is chlorothiazide. There are forty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorothiazide profile page.
Summary for DIURIL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Clinical Trials: | 2 |
Patent Applications: | 3,988 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for DIURIL |
What excipients (inactive ingredients) are in DIURIL? | DIURIL excipients list |
DailyMed Link: | DIURIL at DailyMed |
Recent Clinical Trials for DIURIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Virginia | Phase 4 |
Vanderbilt University | Phase 4 |
Pharmacology for DIURIL
Drug Class | Thiazide Diuretic |
Physiological Effect | Increased Diuresis |
Anatomical Therapeutic Chemical (ATC) Classes for DIURIL
US Patents and Regulatory Information for DIURIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | DIURIL | chlorothiazide sodium | INJECTABLE;INJECTION | 011145-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rising | DIURIL | chlorothiazide | TABLET;ORAL | 011145-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Salix Pharms | DIURIL | chlorothiazide | SUSPENSION;ORAL | 011870-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |